^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

MIR8485 (MicroRNA 8485)

i
Other names: MIR8485, MicroRNA 8485, Hsa-Mir-8485, MIMAT0033692, MI0027288
Associations
Trials
10ms
Differential expression and correlation analysis of global transcriptome for obstructive sleep apnea hypopnea syndrome. (PubMed, Front Mol Biosci)
Both qRT-PCR and transcriptome sequencing analysis showed similar trends. This provides more theoretical basis for exploring the complex molecular mechanisms of global transcriptome in the development of OSAHS.
Journal
|
MIR8485 (MicroRNA 8485)
11ms
MulNet: a scalable framework for reconstructing intra- and intercellular signaling networks from bulk and single-cell RNA-seq data. (PubMed, Brief Bioinform)
Overall, MulNet enables high-resolution reconstruction of intra- and intercellular communication from both bulk and single-cell data. The MulNet code and application are available at https://github.com/free1234hm/MulNet.
Journal
|
MIR8485 (MicroRNA 8485)
almost2years
Unveiling the Molecular Mechanism of Trastuzumab Resistance in SKBR3 and BT474 Cell Lines for HER2 Positive Breast Cancer. (PubMed, Curr Issues Mol Biol)
Moreover, it indicated that miR-4701-5p was highly expressed as compared to TFRC in the SKBR3 cell line. These results unveil key genes and miRNAs as molecular regulators for trastuzumab resistance.
Preclinical • Journal
|
HER-2 (Human epidermal growth factor receptor 2) • BIRC5 (Baculoviral IAP repeat containing 5) • E2F1 (E2F transcription factor 1) • MIR574 (MicroRNA 574) • USP1 (Ubiquitin Specific Peptidase 1) • MIR8485 (MicroRNA 8485)
|
HER-2 positive
|
Herceptin (trastuzumab)
2years
Cancer-associated fibroblasts secret extracellular vesicles to support cell proliferation and epithelial-mesenchymal transition in laryngeal squamous cell carcinoma. (PubMed, Mol Cell Probes)
Moreover, our rescue experiments evidenced that cancer-associated fibroblasts-derived LncRNA TUC338-containing extracellular vesicles-induced supportive effects in LSCC aggressiveness were all abrogated by overexpressing miR-8485 and silencing CBX2. Collectively, this study is the first to identify a novel m6A/LncRNA TUC338/miR-8485/CBX2 axis in CAFs-EVs-mediated LSCC development, and to show its potential as a diagnostic biomarker for LSCC.
Journal
|
CBX2 (Chromobox 2) • METTL3 (Methyltransferase Like 3) • MIR8485 (MicroRNA 8485)
over2years
MicroRNA networks linked with BRCA1/2, PTEN, and common genes for Alzheimer's disease and breast cancer share highly enriched pathways that may unravel targets for the AD/BC comorbidity treatment. (PubMed, Comput Biol Chem)
Those 49 miRNAs regulate the expression of 122 genes in AD and 93 genes in BC, from which 26 genes are common genes for AD and BC involved in neuron differentiation and genesis, cell differentiation and migration, regulation of cell cycle, and cancer development. Additionally, the highly enriched pathway was associated with diabetic complications, pointing out possible interplay among molecules underlying BC, AD, and diabetes pathology.
Journal • BRCA Biomarker
|
BRCA1 (Breast cancer 1, early onset) • BRCA2 (Breast cancer 2, early onset) • PTEN (Phosphatase and tensin homolog) • MIR17HG (MiR-17-92a-1 Cluster Host Gene) • MIR17 (MicroRNA 17) • MIR124-3 (MicroRNA 124-3) • MIR6127 (MicroRNA 6127) • MIR6785 (MicroRNA 6785) • MIR6870 (MicroRNA 6870) • MIR8485 (MicroRNA 8485)
over2years
Predictive miRNAs Patterns in Blood of Breast Cancer Patients Demonstrating Resistance Towards Neoadjuvant Chemotherapy. (PubMed, Breast Cancer (Dove Med Press))
MiR-4741 and miR-6831-5p are independent risk factors for breast cancer resistance. This study constructed a nomogram model of NAC resistance in BC based on 5 differentially-expressed serum miRNAs.
Journal
|
MIR8485 (MicroRNA 8485)
|
HR positive